1. Home
  2. MVIS vs PDSB Comparison

MVIS vs PDSB Comparison

Compare MVIS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroVision Inc.

MVIS

MicroVision Inc.

N/A

Current Price

$1.38

Market Cap

45.0M

Sector

Technology

ML Signal

N/A

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

N/A

Current Price

$1.43

Market Cap

42.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MVIS
PDSB
Founded
1993
2005
Country
United States
United States
Employees
N/A
10
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.0M
42.4M
IPO Year
2010
2015

Fundamental Metrics

Financial Performance
Metric
MVIS
PDSB
Price
$1.38
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.3M
★ 11.5M
Earning Date
10-28-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
23.91
★ 28.16
EPS
N/A
★ N/A
Revenue
★ $664,000.00
N/A
Revenue This Year
$1,017.55
N/A
Revenue Next Year
$48.15
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.23
$0.20
52 Week High
$4.90
$1.79

Technical Indicators

Market Signals
Indicator
MVIS
PDSB
Relative Strength Index (RSI) 51.34 60.50
Support Level $0.56 $0.60
Resistance Level $1.89 $1.79
Average True Range (ATR) 0.11 0.22
MACD 0.04 0.01
Stochastic Oscillator 67.05 60.67

Price Performance

Historical Comparison
MVIS
PDSB

About MVIS MicroVision Inc.

Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars. Geographically, the company operates in United States, Germany, and Other foreign countries.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells. The company has determined that it operates as a single reportable segment, developing a growing pipeline of targeted immunotherapies designed to overcome the limitations of current immunotherapy.

Share on Social Networks: